TherapeuticsMD, Inc. (TXMD) Net margin 2016–2025
TherapeuticsMD, Inc. (TXMD) net profit margin by fiscal year — reported net income divided by reported revenue.
-18.8%FY2025 · since FY2016: -464.3% → -18.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -18.8% | +105.0 pp |
| FY2024 | -123.9% | +665.6 pp |
| FY2023 | -789.4% | -949.5 pp |
| FY2022 | 160.1% | +6861.0 pp |
| FY2021 | -6700.9% | -6418.0 pp |
| FY2020 | -282.9% | +71.9 pp |
| FY2019 | -354.8% | +468.9 pp |
| FY2018 | -823.7% | -365.2 pp |
| FY2017 | -458.5% | +5.8 pp |
| FY2016 | -464.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice